瑞财经 刘治颖4月3日，四川新荷花中药饮片股份有限公司(以下简称“新荷花”)在港交所递交招股书，广发证券(香港)、农银国际为联席保荐人。据瑞财社查阅，递交港股招股书前，新荷花曾多次寻求在A股上市，但因诸多因素最终未能成功。最近一次是2024年4月，终止深交所主板辅导备案，并决定寻求港交所上市。招股书显示，新荷花成立于2001年，是中国中药饮片最大的供应商之一。公司的全球业务遍布中国境内大部分省份，...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.